ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ORIC Oric Pharmaceuticals Inc

13.75
0.285 (2.12%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 725,532
Bid Price 12.90
Ask Price 14.48
News -
Day High 14.07

Low
4.69

52 Week Range

High
16.65

Day Low 13.19
Company Name Stock Ticker Symbol Market Type
Oric Pharmaceuticals Inc ORIC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.285 2.12% 13.75 20:00:00
Open Price Low Price High Price Close Price Prev Close
13.52 13.19 14.07 13.75 13.465
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,244 725,532 $ 13.59 $ 9,857,723 - 4.69 - 16.65
Last Trade Time Type Quantity Stock Price Currency
17:37:17 30 $ 14.00 USD

Oric Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
924.4M 67.38M - 0 -89.12M -1.32 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Oric Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ORIC Message Board. Create One! See More Posts on ORIC Message Board See More Message Board Posts

Historical ORIC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week15.1615.3513.1713.73409,520-1.41-9.30%
1 Month12.2016.6511.8614.39797,4231.5512.70%
3 Months9.0916.657.8512.38576,6544.6651.27%
6 Months6.4216.655.279.86505,6257.33114.17%
1 Year4.9616.654.698.80413,6278.79177.22%
3 Years23.4026.702.368.57382,676-9.65-41.24%
5 Years26.0040.812.3612.10348,730-12.25-47.12%

Oric Pharmaceuticals Description

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101, ORIC-944, ORIC-114, and ORIC-533.

Your Recent History

Delayed Upgrade Clock